Community
Tools
Company
Support
Sign in
Join for Free
Join for Free
Community
How are you sequencing menin inhibitors (eg, revumenib) for pediatric patients with relapsed/refractory NPM1-mutated AML?
Are you using immediately at relapse or reserving for later lines?
Good Question
Save
Request Answers
Share
Add Answer
